Liquid naloxone spray
US10617686B2 · kind B2 · utility
7Cited by
15References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2017 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | May 22, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/183
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.